Cargando…
Can the intermittent low-speed function of left ventricular assist device prevent aortic insufficiency?
Aortic insufficiency (AI) is known to associate with a persistently closed aortic valve during continuous-flow ventricular assist device support. Some devices carry an intermittent low-speed (ILS) function, which facilitates aortic valve opening, but whether this function prevents AI is unknown. In...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Japan
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8154761/ https://www.ncbi.nlm.nih.gov/pubmed/33420874 http://dx.doi.org/10.1007/s10047-020-01234-4 |
_version_ | 1783699063210770432 |
---|---|
author | Kohno, Hiroki Matsumiya, Goro Sawa, Yoshiki Fukushima, Norihide Saiki, Yoshikatsu Shiose, Akira Ono, Minoru |
author_facet | Kohno, Hiroki Matsumiya, Goro Sawa, Yoshiki Fukushima, Norihide Saiki, Yoshikatsu Shiose, Akira Ono, Minoru |
author_sort | Kohno, Hiroki |
collection | PubMed |
description | Aortic insufficiency (AI) is known to associate with a persistently closed aortic valve during continuous-flow ventricular assist device support. Some devices carry an intermittent low-speed (ILS) function, which facilitates aortic valve opening, but whether this function prevents AI is unknown. In this study, the Jarvik 2000 device, which is programmed to reduce the pump speed each minute for 8 s, was chosen to examine this potential effect. Prospectively collected data of 85 heart transplant-eligible Jarvik 2000 recipients who met the study criteria (no pre-existing AI and aortic valve surgery) were retrospectively analyzed for the incidence, correlating factors, and clinical outcomes of de novo AI. All data were provided by the Japanese Registry for Mechanically Assisted Circulatory Support. De novo AI occurred in 58 patients, 23 of whom developed at least moderate AI during a median support duration of 23.5 months. Freedom from moderate or greater AI was 84.4%, 66.1% and 60.2% at 1, 2 and 3 years, respectively. Multivariate analyses revealed that progressive AI was correlated with decreased pulse pressure after implantation (hazard ratio 1.060, 95% confidence interval 1.001–1.127, p = 0.045). No correlation was found for mortality or other adverse events, including stroke, bleeding, infection, pump failure, hemolysis, and readmission. The benefit of the Jarvik 2000′s current ILS mode against AI appears to be minimal. However, in this limited cohort where all recipients underwent implantation as a bridge to transplantation, the impact of de novo progressive AI on other clinical adversities was also minimal. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10047-020-01234-4. |
format | Online Article Text |
id | pubmed-8154761 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Japan |
record_format | MEDLINE/PubMed |
spelling | pubmed-81547612021-06-01 Can the intermittent low-speed function of left ventricular assist device prevent aortic insufficiency? Kohno, Hiroki Matsumiya, Goro Sawa, Yoshiki Fukushima, Norihide Saiki, Yoshikatsu Shiose, Akira Ono, Minoru J Artif Organs Original Article Aortic insufficiency (AI) is known to associate with a persistently closed aortic valve during continuous-flow ventricular assist device support. Some devices carry an intermittent low-speed (ILS) function, which facilitates aortic valve opening, but whether this function prevents AI is unknown. In this study, the Jarvik 2000 device, which is programmed to reduce the pump speed each minute for 8 s, was chosen to examine this potential effect. Prospectively collected data of 85 heart transplant-eligible Jarvik 2000 recipients who met the study criteria (no pre-existing AI and aortic valve surgery) were retrospectively analyzed for the incidence, correlating factors, and clinical outcomes of de novo AI. All data were provided by the Japanese Registry for Mechanically Assisted Circulatory Support. De novo AI occurred in 58 patients, 23 of whom developed at least moderate AI during a median support duration of 23.5 months. Freedom from moderate or greater AI was 84.4%, 66.1% and 60.2% at 1, 2 and 3 years, respectively. Multivariate analyses revealed that progressive AI was correlated with decreased pulse pressure after implantation (hazard ratio 1.060, 95% confidence interval 1.001–1.127, p = 0.045). No correlation was found for mortality or other adverse events, including stroke, bleeding, infection, pump failure, hemolysis, and readmission. The benefit of the Jarvik 2000′s current ILS mode against AI appears to be minimal. However, in this limited cohort where all recipients underwent implantation as a bridge to transplantation, the impact of de novo progressive AI on other clinical adversities was also minimal. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10047-020-01234-4. Springer Japan 2021-01-09 2021 /pmc/articles/PMC8154761/ /pubmed/33420874 http://dx.doi.org/10.1007/s10047-020-01234-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Kohno, Hiroki Matsumiya, Goro Sawa, Yoshiki Fukushima, Norihide Saiki, Yoshikatsu Shiose, Akira Ono, Minoru Can the intermittent low-speed function of left ventricular assist device prevent aortic insufficiency? |
title | Can the intermittent low-speed function of left ventricular assist device prevent aortic insufficiency? |
title_full | Can the intermittent low-speed function of left ventricular assist device prevent aortic insufficiency? |
title_fullStr | Can the intermittent low-speed function of left ventricular assist device prevent aortic insufficiency? |
title_full_unstemmed | Can the intermittent low-speed function of left ventricular assist device prevent aortic insufficiency? |
title_short | Can the intermittent low-speed function of left ventricular assist device prevent aortic insufficiency? |
title_sort | can the intermittent low-speed function of left ventricular assist device prevent aortic insufficiency? |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8154761/ https://www.ncbi.nlm.nih.gov/pubmed/33420874 http://dx.doi.org/10.1007/s10047-020-01234-4 |
work_keys_str_mv | AT kohnohiroki cantheintermittentlowspeedfunctionofleftventricularassistdevicepreventaorticinsufficiency AT matsumiyagoro cantheintermittentlowspeedfunctionofleftventricularassistdevicepreventaorticinsufficiency AT sawayoshiki cantheintermittentlowspeedfunctionofleftventricularassistdevicepreventaorticinsufficiency AT fukushimanorihide cantheintermittentlowspeedfunctionofleftventricularassistdevicepreventaorticinsufficiency AT saikiyoshikatsu cantheintermittentlowspeedfunctionofleftventricularassistdevicepreventaorticinsufficiency AT shioseakira cantheintermittentlowspeedfunctionofleftventricularassistdevicepreventaorticinsufficiency AT onominoru cantheintermittentlowspeedfunctionofleftventricularassistdevicepreventaorticinsufficiency |